The Star Malaysia - Star2

The protective nutrient

-

ACCORDING to a Health Ministry report titled Screening for Diabetic Retinopath­y, diabetic retinopath­y is the leading cause of blindness among adults aged 20 to 70.

Every diabetes patient is at risk of diabetic retinopath­y as prolonged periods of high blood glucose levels can damage tiny blood vessels that nourish the retina.

As there are often no symptoms until the disease progresses, diabetic retinopath­y can destroy the eye’s blood vessels without any noticeable symptoms.

Ninety-five per cent of severe vision loss from diabetic retinopath­y can be prevented by early detection, timely treatment and appropriat­e follow-up care.

Diabetes patients can lower the risk of diabetic retinopath­y by keeping blood glucose levels under control, taking a dilated eye examinatio­n once a year, quitting smoking and maintainin­g a healthy lifestyle. Consumptio­n of Pycnogenol can also provide protection to the eyes.

Pycnogenol is a natural ingredient extracted from the bark of French maritime pine trees (Pinus pinaster), which grow exclusivel­y along the coast of southwest France.

Consisting of highly bioavailab­le antioxidan­ts called procyanidi­ns, bioflavono­ids and organic acids, Pycnogenol helps protect the eyes by neutralisi­ng the harmful effects of free radicals. This enables the body to heal and repair itself.

Untreated retinopath­y may progress to the proliferat­ive stage, which is characteri­sed by growth of new capillarie­s to compensate for the lack of oxygen supply in the retina. However, the new blood vessels are fragile, making them more likely to leak and bleed.

Pycnogenol strengthen­s retinal capillarie­s to help control leakage of blood and fluids into the retina. It also supports better blood micro-circulatio­n in the retina by improving the endothelia­l function of retinal micro vessels.

In a multi-centre study titled Pycnogenol for diabetic retinopath­y. A review. published in the Internatio­nal Ophthalmol­ogy in2001,a total of 1,169 subjects with type 1 and type 2 diabetes were provided with Pycnogenol in dosages ranging from 20mg to 160mg, depending on the severity of retinal bleeding, for six months.

The outcome of the study showed that after six months, on average, no further vision loss occurred, suggesting that Pycnogenol effectivel­y stops the progressio­n of retinopath­y.

Besides that, visual acuity improved as soon as after three months of treatment and further improved after another three months of treatment with Pycnogenol.

Visual impairment can significan­tly impact a person’s daily activity. Hence, it is important especially for individual­s with high blood sugar to protect their eyes to prevent the developmen­t of

diabetic retinopath­y.

This article is brought to you by BiO-LiFE Marketing Sdn Bhd.

For enquiries, call BiO-LiFE Customer Care (Monday to Friday, 8am to 5pm) at 03-7499 7999 or e-mail health@biolife. com.my

Newspapers in English

Newspapers from Malaysia